Clinical trial
Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
NCT03517319 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 1, 2016
- Completion date
- June 30, 2018
- Enrollment
- 78 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity as sequela of stroke